96: Complexities With Cognitive Screening in Primary Care Settings episode artwork

EPISODE · Aug 25, 2023 · 22 MIN

96: Complexities With Cognitive Screening in Primary Care Settings

from NeurologyLive® Mind Moments® · host NeurologyLive

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this episode, Nicole Fowler, PhD, director of research for internal medicine and geriatrics at Indiana University School of Medicine, discussed the DAVOS Alzheimer's Collaborative DIGITAL Demonstration Project, an initiative to help understand the feasibility, acceptability, and implementation of digital cognitive screening tools in primary care settings. Specifically, she spoke on how these tools will be used as more novel therapeutics for Alzheimer disease emerge, the challenges with screening patients large-scale, and how blood tests and other biomarkers will play a role going forward. Looking for more Alzheimer disease/dementia discussion? Check out the NeurologyLive® Alzheimer disease/dementia clinical focus page.Episode Breakdown: 1:15 – Objectives of DAVOS Project, overview of presentation from AAIC 6:55 – Complexities and challenges with screening in primary care settings 10:30 – Neurology News Minute 13:25 – Incorporating screening procedures with emerging therapies 12:30 – Future role of digital technologies and blood tests This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com.The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Expanded Indication of DaxibotulinumtoxinA to Treat Cervical Dystonia Exon 44 Skipping Agent AOC 1044 Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy CGRP Medication Atogepant Gains European Commission Approval as Migraine Preventive FDA Approves Neurocrine Biosciences’ Valbenazine for Huntington Disease Chorea Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Episode metadata supplied by the publisher feed · Published Aug 25, 2023

Embed this episode

NOW PLAYING

96: Complexities With Cognitive Screening in Primary Care Settings

0:00 22:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of NeurologyLive® Mind Moments®?

This episode is 22 minutes long.

When was this NeurologyLive® Mind Moments® episode published?

This episode was published on August 25, 2023.

Can I download this NeurologyLive® Mind Moments® episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!